Shockwave Medical, Inc.·4

Feb 22, 8:15 PM ET

MOLL FREDERIC H 4

4 · Shockwave Medical, Inc. · Filed Feb 22, 2024

Insider Transaction Report

Form 4
Period: 2024-02-21
Transactions
  • Sale

    Common Stock

    2024-02-21$259.91/sh5,528$1,436,782293,611 total
  • Sale

    Common Stock

    2024-02-21$255.95/sh16,464$4,213,961324,613 total
  • Sale

    Common Stock

    2024-02-21$258.09/sh8,649$2,232,220301,799 total
  • Sale

    Common Stock

    2024-02-21$261.96/sh1,200$314,352287,521 total
  • Sale

    Common Stock

    2024-02-21$255.14/sh6,444$1,644,122341,077 total
  • Sale

    Common Stock

    2024-02-21$256.82/sh14,165$3,637,855310,448 total
  • Sale

    Common Stock

    2024-02-21$258.95/sh2,660$688,807299,139 total
  • Sale

    Common Stock

    2024-02-21$260.80/sh4,890$1,275,312288,721 total
Footnotes (8)
  • [F1]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $254.43 to $255.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $255.43 to $256.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $256.43 to $257.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $257.43 to $258.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F5]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $258.43 to $259.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F6]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $259.44 to $260.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F7]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $260.45 to $261.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F8]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $261.54 to $262.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Documents

1 file
  • 4
    wk-form4_1708650890.xmlPrimary

    FORM 4